88 related articles for article (PubMed ID: 11160754)
21. Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.
Krauer KG; Kienzle N; Young DB; Sculley TB
Virology; 1996 Dec; 226(2):346-53. PubMed ID: 8955054
[TBL] [Abstract][Full Text] [Related]
22. A novel EBNA-1 tag system for high level expression and efficient detection of fusion proteins in vitro and in vivo.
Chen MR; Huang H; Fen CY; Chen JY
J Virol Methods; 2000 Mar; 85(1-2):35-41. PubMed ID: 10716336
[TBL] [Abstract][Full Text] [Related]
23. Mapping EBNA-1 domains involved in binding to metaphase chromosomes.
Marechal V; Dehee A; Chikhi-Brachet R; Piolot T; Coppey-Moisan M; Nicolas JC
J Virol; 1999 May; 73(5):4385-92. PubMed ID: 10196336
[TBL] [Abstract][Full Text] [Related]
24. The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif.
Ansieau S; Leutz A
J Biol Chem; 2002 Feb; 277(7):4906-10. PubMed ID: 11733528
[TBL] [Abstract][Full Text] [Related]
25. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
Chen A; Divisconte M; Jiang X; Quink C; Wang F
J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies.
Sauder C; Götzinger N; Schubach WH; Horvath GC; Kremmer E; Krebs A; König S; Zimber Strobl U; Mueller Lantzsch N; Grässer FA
J Gen Virol; 1996 May; 77 ( Pt 5)():991-6. PubMed ID: 8609497
[TBL] [Abstract][Full Text] [Related]
28. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
Exp Cell Res; 2005 Feb; 303(1):47-55. PubMed ID: 15572026
[TBL] [Abstract][Full Text] [Related]
30. Nuclear localization of the Epstein-Barr virus EBNA3B protein.
Burgess A; Buck M; Krauer K; Sculley T
J Gen Virol; 2006 Apr; 87(Pt 4):789-793. PubMed ID: 16528026
[TBL] [Abstract][Full Text] [Related]
31. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
32. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production.
Geisse S; Henke M
J Struct Funct Genomics; 2005; 6(2-3):165-70. PubMed ID: 16211514
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events.
Zhao B
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112815
[TBL] [Abstract][Full Text] [Related]
34. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
[TBL] [Abstract][Full Text] [Related]
35. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
Mühe J; Wang F
PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
[TBL] [Abstract][Full Text] [Related]
36. The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.
Friberg A; Thumann S; Hennig J; Zou P; Nössner E; Ling PD; Sattler M; Kempkes B
PLoS Pathog; 2015 May; 11(5):e1004910. PubMed ID: 26024477
[TBL] [Abstract][Full Text] [Related]
37. Protein-protein interactions between proteins of Citrus tristeza virus isolates.
Nchongboh CG; Wu GW; Hong N; Wang GP
Virus Genes; 2014 Dec; 49(3):456-65. PubMed ID: 25064367
[TBL] [Abstract][Full Text] [Related]
38. Transcription factor RBPJ/CSL: a genome-wide look at transcriptional regulation.
Miele L
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14715-6. PubMed ID: 21873209
[No Abstract] [Full Text] [Related]
39. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
[TBL] [Abstract][Full Text] [Related]
40. Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.
Gross H; Barth S; Palermo RD; Mamiani A; Hennard C; Zimber-Strobl U; West MJ; Kremmer E; Grässer FA
Virology; 2010 Feb; 397(2):299-310. PubMed ID: 19969318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
